Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Free Cash Flow (2023 - 2025)

Contineum Therapeutics has reported Free Cash Flow over the past 3 years, most recently at -$12.9 million for Q4 2025.

  • Quarterly results put Free Cash Flow at -$12.9 million for Q4 2025, down 29.67% from a year ago — trailing twelve months through Dec 2025 was -$55.3 million (down 68.11% YoY), and the annual figure for FY2025 was -$55.3 million, down 68.11%.
  • Free Cash Flow for Q4 2025 was -$12.9 million at Contineum Therapeutics, down from -$12.3 million in the prior quarter.
  • Over the last five years, Free Cash Flow for CTNM hit a ceiling of $40.6 million in Q2 2023 and a floor of -$15.7 million in Q2 2025.
  • Median Free Cash Flow over the past 3 years was -$9.3 million (2024), compared with a mean of -$5.8 million.
  • Peak annual rise in Free Cash Flow hit 10.0% in 2024, while the deepest fall reached 121.2% in 2024.
  • Contineum Therapeutics' Free Cash Flow stood at -$11.0 million in 2023, then grew by 10.0% to -$9.9 million in 2024, then dropped by 29.67% to -$12.9 million in 2025.
  • The last three reported values for Free Cash Flow were -$12.9 million (Q4 2025), -$12.3 million (Q3 2025), and -$15.7 million (Q2 2025) per Business Quant data.